The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity. It ...

Shanghai-based medical device start-up United InnoMed plans to collaborate with medical institutions in Hong Kong on clinical ...

Eli Lilly & Co.’s shares saw the biggest one-day drop since 2008 after CVS Health Corp. announced a plan to drop its ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

In a landmark decision, the World Health Organization (WHO) is poised to officially endorse the use of weight-loss drugs for ...

The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.